Immunoparesis in symptomatic multiple myeloma at diagnosis affects PFS with bortezomib-containing induction therapy, but not ASCT consolidation

Overview of attention for article published in International Journal of Hematology, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 15,023 followers.

RT @Myeloma_Doc: Immunoparesis in symptomatic multiple #myeloma patients at diagnosis affects PFS with #Velcade-containing induction therap…

Immunoparesis in symptomatic multiple #myeloma patients at diagnosis affects PFS with #Velcade-containing induction therapy, but not ASCT consolidation: https://t.co/AaGNtOHBqm. https://t.co/9lF9W4c8FF